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The Genetic Associations and Epistatic Effects
of the CCR5 Promoter and CCR2-V64I Polymorphisms
on Susceptibility to HIV-1 Infection in a Northern
Han Chinese Population
Jiapeng Lu,1,2,* Aijuan Sheng,3 Youxin Wang,1,2,* Ling Zhang,1,2 Jingjing Wu,1,2 Manshu Song,1,2 Yan He,1,2
Xinwei Yu,1,2 Feifei Zhao,1,2 Yezhou Liu,1,2 Shuang Shao,1,2 Jie Lan,4 Hao Wu,3 and Wei Wang2,4,5
The outcome of human immunodeficiency virus (HIV)-1 infection and course to AIDS are variable among indi-
viduals. Both chemokine receptor 5 (CCR5) and CCR2 gene polymorphisms play essential roles in the susceptibility
of HIV-1 infection. To investigate the main and epistatic effects of the CCR5 promoter and CCR2-V64I polymor-
phisms on HIV-1 infection in the Northern Han Chinese, subjects of 91 HIV-1-infected patients and 91 health controls
were recruited. Single-nucleotide polymorphisms (SNPs) in the CCR5 promoter region and CCR2-V64I variants were
genotyped. In the single-locus analysis, CCR5 58755-G and CCR5 59653-T alleles were significantly associated with
HIV-1 infection (odds ratio [OR]=0.529, 95% confidence interval [CI]: 0.295–0.948; OR=1.710, 95% CI: 1.039–2.814).
After adjustment with age and gender, subjects with the CCR5 59653-CT genotype showed the increased risk of HIV-
1 infection compared with those with the wild-type CC genotype (adjusted OR=2.502; 95% CI: 1.332–4.698). No
positive association was observed in other SNPs. Haplotype-based association analysis revealed that the haplotype
TATGC was associated with the susceptibility to HIV-1 infection ( p=0.003). Besides, we found the significant
epistatic effects between the CCR5 58755-A/G and CCR5 59029-A/G polymorphisms associated with the lower risk
of HIV-1 infection. In addition, we also identified the best three-factor interaction model, including the CCR5 58755-
A/G, 59029-A/G, and CCR2-V64I polymorphisms, indicating that there were also strong gene–gene interactions
between the CCR5 promoter and CCR2 polymorphisms on the susceptibility of HIV-1 infection. These findings
contribute to understanding the genetic mechanism for the susceptibility of HIV-1 infection in Northern Han Chinese.
Introduction
The history of human immunodeficiency virus (HIV)-1infection and the course of AIDS have demonstrated
considerable variability in individuals. This is partially due to
the extreme heterogeneity in immune responsiveness. Some
individuals develop AIDS within 2–3 years and are named as
rapid-progress individuals. Nevertheless, some individuals
are uninfected despite having being in contact with virus and
others maintain normal CD4 counts for 10 years or more
(Pantaleo and Fauci, 1996). The interindividual variability
observed in terms of HIV-1 infection is regulated by multiple
host genetic factors, for example, chemokine receptors (CCR),
and their ligands, some of which are directly involved in the
procedure of HIV-1 cell entry (Arenzana-Seisdedos and Par-
mentier, 2006). Several studies have reported that these gene
variants might influence susceptibility to HIV-1 infection and
progression to AIDS in different populations (Hogan and
Hammer, 2001; Arenzana-Seisdedos and Parmentier, 2006).
Among the host factors, the CCR5 promoter and CCR2-V64I
polymorphisms have remarkable contribution to HIV-1 in-
fection or the progression of HIV to AIDS, in different ethnic
populations (Hogan and Hammer, 2001).
CCR5, the HIV-1 coreceptor, mediates the viral envelope
fusion with the membrane of CD4+ T cells (Berger et al., 1998).
The CCR5 gene is located in the 3p21.3 region of human ge-
nome (Samson et al., 1996b). The 32-bp deletion of the CCR5
gene in the coding sequence leads to effectively protection
against HIV-1 infection in homozygous individuals and de-
layed progression to AIDS in heterozygotes (Huang et al., 1996;
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Liu et al., 1996;O’Brien et al., 1997; Dean et al., 2002). The allele of
CCR5-D32 is common in the European populations, but almost
absent from the African and Asian populations (Martinson
et al., 1997). In addition, the CCR5 promoter polymorphisms,
CCR5 59029-G homozygotes, were associated with delayed
disease progression compared with the CCR5 59029-A homo-
zygotes (McDermott et al., 1998; Clegg et al., 2000; Knudsen
et al., 2001; Kaur et al., 2007); while CCR5 59353-Cwas reported
to be associated with HIV pathogenesis in the Korean popu-
lations ( Jang et al., 2008), as well as with increased risk of ver-
tical transmission of HIV-1 infection in Brazilian children (de
Souza et al., 2006). In the Northern Chinese population, no
significant association was found on the single-nucleotide
polymorphism (SNPs) in theCCR5 promoter region. However,
a novel haplotype (GGTAC: CCR5 58934-G/T, 59029-A/G,
59353-C/T, 59402-A/G, and 59653-C/T) was significantly as-
sociated with HIV-1 infection (Xu et al., 2010).
CCR2 is the receptor for the b-chemokine macrophage
chemoattractant protein 1–4 (MCP 1–4) acting as a coreceptor
of rare R5 and dual-tropic R5X4 viruses to invade host cells
(Simmons et al., 1996). CCR2 is closely linked with the CCR5
gene, with 17.5-kb downstream distance (Samson et al.,
1996a). A mutant of the CCR2 gene at position 64 in the first
transmembrane segment, a valine (V) of the receptor replaced
by an isoleucine (I), has been reported (Smith et al., 1997). The
frequency of the CCR2-64I allele was 10%–20% among dif-
ferent populations (Su et al., 1998). In the overall Chinese Han
population, the frequency of the CCR2-64I allele was *20%
(Wang et al., 2001). According to the results of different
studies, CCR2-64I had no influence on the incidence of HIV-1
infection, but heterozygotes were found to display slower
progression to AIDS compared to homozygotes for the wild
type (Smith et al., 1997; Rizzardi et al., 1998; Easterbrook et al.,
1999). A recent study identified that the allele frequencies of
CCR2-64I were 14.7% in the HIV-1-infected patients and
18.6% in the healthy controls in the Northern Chinese popu-
lation, and confirmed the association of the CCR2-64I allele
with slower disease progression (Xu et al., 2009).
In addition to the main effects of individual SNPs, complex
diseases may be influenced by SNP-SNP interaction, which is
named as epistasis (Cordell, 2009). The finding of SNP-SNP
interaction could provide valuable information on the un-
derlying biochemical and biological pathways of HIV infec-
tion (Moore, 2003). Based on the reports that the protective
effect of the CCR2-64I allele may attribute to the link with the
variants in the CCR5 promoter region (Carrington et al., 1999;
Gonzalez et al., 1999), it may be assumed that the interaction of
the CCR5 promoter and the CCR2 gene might take an indis-
pensable effect on the process of HIV-1 infection in the Chi-
nese Han population.
This study aims to detect the frequencies of seven CCR5
promoter region polymorphisms (CCR5 58755-A/G, 58934-
G/T, 59029-A/G, 59353-T/C, 59356-C/T, 59402-A/G, and
59653-C/T), and CCR2-V64I in a Northern Han Chinese
population, and to investigate the main effects and epistatic
effects on susceptibility to HIV-1 infection.
Materials and Methods
Study subjects
This study recruited a total of 91 HIV-1-infected patients
(45men and 46women) from Beijing YouAnHospital, Capital
Medical University. The mean age was 40.08 – 7.30 years old
(range 25–55 years). The average CD4 + T lymphocyte count
was 395.4 cells/mL (range 186–759 cells/mL). Among them, 81
(89.0%) cases were infected through blood contact; 6 (6.6%)
individuals were infected through sexual transmission; and 4
(4.4%) cases were not clear with respect to the transmission
route. The HIV-1-infected patients were identified by western
blotting. Matching age and gender with HIV-1-infected pa-
tients, 91 healthy controls (51 men and 40 women) were col-
lected from the Physical Health Examination Centre, Beijing
TongRen Hospital, Capital Medical University. The mean age
was 40.55– 10.95 years old (range 22–58 years). Both HIV-1-
infected patients and healthy controls are Northern Han Chi-
nese. The distributions of age and genderwere not significantly
different between the cases and controls (t= 0.342, p=0.732;
v2= 0.794, p= 0.373). Informed consent was obtained from each
participant, and the study was approved by the ethics com-
mittee of the Capital Medical University (Beijing, China).
DNA preparation and SNP genotyping
Whole-genome DNA was extracted by the DNeasy Blood
& Tissue Kit (Qiagen) according to the standard protocol. We
designed amplification primers for the seven CCR5 promoter
and CCR2-V64I polymorphisms using NCBI/Primer-BLAST.
The primer sequences of the CCR5 promoter polymorphisms
were 5¢-TAG GAT TGG GGG CAC GTA ATT T-3¢ (forward)
and 5¢-CTC AAA CTC CCT GCA CCT TAG ACT A-3¢ (re-
verse), while for the CCR2-V64I polymorphism, the primer
sequences were 5¢-GGA TTGAACAAGGACGCATTT CCC
C-3¢ (forward) and 5¢-TTG CAC ATT GCA TTC CCA AAG
ACC C-3¢ (reverse). Polymerase chain reactions (PCRs) were
executed in a 50-mL volume containing 5 mL 10 · PCR buffer,
4 mL dNTPs (2.5mM), 1mL forward primer (20 mM), 1 mL re-
verse primer (20mM), 2 mL genomic DNA, 0.25 mL Taq poly-
merase (5U/mL, TaKaRa), and 36.75mL deionized H2O. PCRs
were initiated by denaturation at 95C for 5min, followed by
40 cycles: 30 s at 95C, 30 s at the optimal annealing temper-
ature, and 60 s at 72C, and then PCR products were pro-
longed for 6min at 72C andwere finally held at 4C. The PCR
products were then separated by 2.0% agarose gel electro-
phoresis. All amplified DNA fragments were resequenced by
Sangon Corp.. The genotypes of our investigated polymor-
phisms were derived from comparing the CCR5 and CCR2
gene sequences (GenBank accession Nos: AF031237 and
AB119271, respectively).
Statistical analysis
The distributions of the allele and genotype frequencies
were analyzed using the v2 test. The single-locus association
and SNP-SNP interactions were estimated by computing the
odds ratios (ORs) and 95% confidence intervals (CIs) with
adjustment for age and gender using logistic regression
analysis. All of those analyses were completed by SPSS13.0
software. Deviations from the Hardy–Weinberg equilibrium
in the controls were tested online (http://ihg2.helmholtz-
muenchen.de/cgi-bin/hw/hwa1.pl). The frequencies of the
haplotypes and the association analyses were evaluated using
Haploview software 4.1. p< 0.05 was considered statistically
significant.
To identify the SNP-SNP interactions, the linkage disequi-
librium (LD) of each two loci was calculated in both cases and
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controls (Zhao et al., 2006). Gene–gene interactions were de-
termined by nonparametric multifactor dimensionality re-
duction (MDR) software (version 2.0; Computational
Genetics Laboratory, Dartmouth Medical School, Hanover,
NH; www.epistasis.org). The MDR approach is a model-free
and nonparametric analysis method for gene–gene and gene–
environment interaction studies in case–control and discor-
dant sib-pair study designs (Hahn et al., 2003). We applied the
MDRmethod for case–control study designs using the 10-fold
cross-validation procedure 10 times, with a different number
of factors, to reduce the chance of observing spurious results
due to chance divisions of the data. Empirical p-values were
based on the number of prediction errors estimated among
the 1000 simulations that were as small as or smaller than the
observed prediction errors. The best MDRmodel was selected
as the one with maximum average testing balanced accuracy
and also high cross-validation consistency (CVC) (Ritchie
et al., 2001; Hahn et al., 2003).
Results
Allele and genotype frequencies
The genotype distribution of all investigated SNPs fol-
lowed the Hardy–Weinberg equilibrium in the controls
( p > 0.05, Table 1). The T allele ofCCR5 59356-C/Twas unable
to be found, so this SNPwas excluded from analysis. All of the
Table 1. Allele Frequencies of the CCR5 Promoter and CCR2-V64I Polymorphisms in the Cases and Controls
Case Control
SNPs MAF HWE p-value n Frequency (%) n Frequency (%) p-Value OR (95% CI)
CCR5 58755-A/G 0.157 0.772 21 11.5 36 19.8 0.031a 0.529 (0.295–0.948)
CCR5 58934-G/T 0.484 0.533 88 48.4 100 54.9 0.208 0.768 (0.508–1.159)
CCR5 59029-A/G 0.423 0.529 78 42.9 75 41.2 0.750 1.070 (0.706–1.622)
CCR5 59353-C/T 0.382 0.445 71 39.0 68 37.4 0.746 1.072 (0.702–1.637)
CCR5 59402-A/G 0.462 0.272 87 47.8 80 44.0 0.462 1.168 (0.773–1.764)
CCR5 59653-C/T 0.231 0.476 50 27.5 33 18.1 0.034a 1.710 (1.039–2.814)
CCR2-V64I(G/A) 0.209 0.476 43 23.6 33 18.1 0.197 1.397 (0.840–2.324)
aSignificant at the level of p < 0.05.
HWE, Hardy–Weinberg equilibrium in controls; OR, odds ratio; 95% CI, 95% confidence interval; MAF, minor allele frequencies; SNP,
single-nucleotide polymorphisms.
Table 2. Genotype Frequencies and Association Results of the CCR5 Promoter and CCR2-V64I
Polymorphisms in the Cases and Controls
n (%)
SNPs Genotype/allele HIV-1 infected Healthy control p-Valuea Adjusted OR (95% CI)b
CCR5 58755-A/G AA 71 (78.0) 59 (64.8) 0.099 1.000
AG 19 (20.9) 28 (30.8) 0.558 (0.281–1.109)
GG 1 (1.1) 4 (4.4) 0.198 (0.021–1.830)
CCR5 58934-G/T GG 24 (26.4) 17 (18.7) 0.413 1.000
GT 46 (50.5) 48 (52.7) 0.701 (0.332–1.481)
TT 21 (23.1) 26 (28.6) 0.586 (0.250–1.373)
CCR5 59029-A/G AA 11 (12.1) 14 (15.4) 0.750 1.000
AG 56 (61.5) 47 (51.6) 1.591 (0.654–3.868)
GG 24 (26.4) 30 (33.0) 1.079 (0.411–2.834)
CCR5 59353-C/T CC 12 (13.2) 11 (12.1) 0.944 1.000
CT 47 (51.6) 46 (50.5) 0.969 (0.387–2.430)
TT 32 (35.2) 34 (37.4) 0.885 (0.341–2.298)
CCR5 59402-A/G AA 17 (18.7) 15 (16.5) 0.689 1.000
AG 53 (58.2) 50 (54.9) 0.953 (0.429–2.116)
GG 21 (23.1) 26 (28.6) 0.725 (0.293–1.791)
CCR5 59653-C/T CC 44 (48.4) 62 (68.1) 0.015c 1.000
CT 44 (48.4) 25 (27.5) 2.502 (1.332–4.698)c
TT 3 (3.2) 4 (4.4) 1.029 (0.218–4.864)
CT/TT 47 29 2.296 (1.250–4.218)c
CCR2-V64I(G/A) GG 51 (56.0) 62 (68.1) 0.171 1.000
GA 37 (40.7) 25 (27.5) 1.835 (0.967–3.483)
aTwo-sided T-test for the distributions of genotype and allele frequencies.
bAdjusted for age and gender in a logistic regression model.
cSignificant at the level of p < 0.05.
HIV, human immunodeficiency virus.
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other seven SNPs were included in the subsequent analyses.
Theminor allele frequencies of these SNPs (CCR5 58755-A/G,
58934-G/T, 59029-A/G, 59353-T/C, 59402-A/G, 59653C/T,
and CCR2-V64I) were 11.5%, 48.4%, 42.9%, 39.0%, 47.8%,
27.5% and 23.6% in HIV-1-infected patients, and 19.8%,
54.9%, 41.2%, 37.4%, 44.0%, 18.1% and 18.1% in healthy
controls, respectively (Table 1). The average allele frequency
of CCR2-V64I was 20.9% in all subjects, which was 23.6% in
the cases and 18.1% in the controls.
Association of the CCR5 promoter and CCR2-V64I
polymorphisms on HIV-1 infection
The G allele of CCR5 58755-A/G was significantly associ-
ated with a lower risk of HIV-1 infection ( p = 0.031,
OR= 0.529, 95% CI: 0.295–0.948, Table 1). An opposite result
was found between the CCR5 59653T allele and susceptibility
to HIV-1 infection ( p= 0.034, OR= 1.710, 95%CI: 1.039–2.814).
Adjusted for age and gender, the CCR5 59653-CT genotype,
compared with the wild-type CC genotype, was associated
with higher susceptibility to HIV-1 infection (adjusted
OR= 2.502, 95% CI: 1.332–4.698, Table 2). Because of the rare
count (N = 3) of genotype TT in the CCR5 59653-C/T poly-
morphism, we combined genotype TT into heterozygous CT.
It was found that a statistically significantly higher risk was
observed in the genotypes CT/TT compared with the geno-
type CC (OR = 0.51, 95% CI: 0.32–0.80), suggesting the variant
T allele ofCCR5 59653-C/T increased the probability of HIV-1
infection for the carriers. No significant association was found
in other SNPs.
In CCR5 promoter region, five SNPs (CCR5 58755-A/G,
58934-G/T, 59029-A/G, 59353-T/C, and 59402-A/G) had
strong evidence of LD (Fig. 1). We selected the haplotypes
with frequencies above 1.0%, and eight haplotypes were
identified (Table 3). The most common CCR5 haplotype was
TGTGC (47.9%), followed by GACAT (22.2%), GACAC
(12.4%), GATAC (5.1%), GGTAC (3.2%), GGTGC (2.8%),
TATGC (2.6%), andGGCAC (2.1%). The frequency of TATGC
haplotype in HIV-1-infected patients was significantly lower
than that of controls (0.1% vs. 5.1%, v2= 8.899, p= 0.003).
Interaction of the CCR5 promoter and CCR2-V64I
variants on HIV-1 infection
All D¢ values among the CCR5 promoter and CCR2-V64I
polymorphisms were larger than 0.90 in the patients, but
weak LD was observed in the controls (five D¢ values were
< 0.80, and data were not shown), indicating that epistatic
effects are involved in the genetic effects on the susceptibility
FIG. 1. LD plot of the CCR5 promoter and CCR2-V64I
polymorphisms. The LD plot was generated by Haploview
software. The rs number (from left to right) corresponds to
the SNPs (rs1799864: CCR2-V64I, rs2856758: CCR5 58755-A/
G, rs2734648: CCR5 58934-G/T, rs1799987: CCR5 59029-A/
G, rs1799988: CCR5 59353-T/C, rs41469351: CCR5 59356-C/
T, rs1800023: CCR5 59402-A/G, and rs1800024: CCR5 59653-
C/T). The level of pairwise D¢ indicating the degree of LD
between two SNPs is shown in the LD structure. Strong
evidence of LD is shown in black or dark gray, while weak
evidence in white. CCR, chemokine receptor 5; SNP, single-
nucleotide polymorphisms; LD, linkage disequilibrium.
Table 3. Haplotype Frequencies of the CCR5
Promoter and CCR2-V64I Polymorphisms
in the Cases and Controls
Haplotype
Frequencies
(%)
Frequencies
in the
cases (%)
Frequencies
in the
controls (%)
w2
value p-Value
TGTGC 47.9 47.6 48.1 0.007 0.932
GACAT 22.2 26.3 18.1 3.512 0.061
GACAC 12.4 10.8 14.0 0.876 0.349
GATAC 5.1 5.7 4.5 0.264 0.607
GGTAC 3.2 3.1 3.3 0.004 0.947
GGTGC 2.8 3.9 1.7 1.651 0.199
TATGC 2.6 0.1 5.1 8.899 0.003a
GGCAC 2.1 0.7 3.5 3.389 0.066
aSignificant at the level of p < 0.05.
Table 4. Multifactor Dimensionality Reduction
-Based Interaction Models of the CCR5 Promoter
and CCR2-V64I Polymorphisms on Human
Immunodeficiency Virus-1 Infection
Model
Training
bal. acc.
Testing
bal. acc. CVC
CCR5 59653-C/T 0.6044 0.5824a 10/10
CCR5 58755-A/G and
59029-A/G
0.6374 0.6209a 10/10
CCR5 58755-A/G,
59029-A/G and
CCR2-V64I (G/A)
0.6825 0.6154a 10/10
CCR5 58755-A/G,
58934-G/T, 59029-A/G
and CCR2-V64I (G/A)
0.6886 0.5714a 7/10
aMultifactor dimensionality reduction model is considered statis-
tically significant ( p < 0.05) if testing accuracy is greater than testing
accuracy cutoff based on a 1,000-fold permutation test for up to
three-factor interactions.
Training bal. acc., training balance accuracy; testing bal. acc.,
testing balance accuracy; CVC, cross-validation consistency.
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of HIV-1infection. Then, the potential interaction model of the
CCR5 promoter and CCR2-V64I polymorphisms was esti-
mated using the MDRmethod (Table 4 and Fig. 2). The CCR5
59653-C/T polymorphism was the strongest single factor for
the risk of HIV-1 infection with testing accuracy = 0.5824 and
CVC = 10/10. Yet, according to the selected principle of best
model, the best interaction model was the two-factor model
(CCR5 58755-A/G and 59029-A/G) with an improved testing
accuracy to 62.09%, a perfect CVC of 10, and statistically
significant ( p= 0.001). The strongest interaction between
CCR5 58755-A/G and 59029-A/G was directly shown in
black in the interaction dendrogram (Fig. 2). In addition, it
was observed that the three-factor model (CCR5 58755-A/G,
59029-A/G, and CCR2-V64I) was with less testing accuracy
(0.6154) and complete CVC. The CCR2-V64I polymorphism
was situated on the same branch with the best two-factor
model (dark gray in Fig. 2), suggesting that there were also
strong gene–gene interactions between the CCR5 promoter
and CCR2 polymorphisms on the susceptibility of HIV-1 in-
fection.
Finally, logistic regression models were evaluated in the
best interactionmodel identified byMDR (Table 5). The CCR5
59029-A/G polymorphism as a main effect was a statistically
significant predictor for the risk of HIV-1 infection ( p= 0.025;
AG vs. AA: OR= 5.671; 95% CI: 1.394–23.073), indicating that
CCR5 59029-AG genotype carriers were more vulnerable to
HIV-1 infection in a Northern Han Chinese population. The
interaction between CCR5 58755-A/G and CCR5 59029-A/G
was significantly associated with the susceptibility of HIV-1
infection ( p = 0.014). The interaction showed the protective
effect on the risk of HIV-1 infection in aNorthernHanChinese
population (AG*AG vs. AA*AA: OR= 0.025; 95% CI: 0.003–
0.235; AG*GG vs. AA*AA: OR= 0.026; 95% CI: 0.001–0.544).
Discussion
Although most genetic susceptibility studies focus on the
gene’s main effects on HIV-1 infection, the SNP-SNP inter-
action may account for the variability of the risk of HIV-1
infection, as well. In this study, it was observed that the CCR5
58755-A/G and CCR5 59653-C/T variants have their main
effects on susceptibility to HIV-1 infection in a Northern Han
Chinese population. In addition, significant epistatic effects
were obtained between the CCR5 58755-A/G and 59029-A/G
polymorphisms on the risk of HIV-1 infection in Northern
Han Chinese.
The G allele frequency ofCCR5 58755-A/Gwas 15.7% in all
investigated individuals, which was substantially higher than
results reported before (Xu et al., 2010). Statistically significant
allelic difference was found between cases and controls
( p = 0.031, OR= 0.529, 95% CI: 0.295–0.948), suggesting that
the G allele of CCR5 58755-A/G is a protective factor for HIV-
1 infection in a Northern Han Chinese population. Further-
more, the CCR5 59653-T allele is significantly associated with
a higher risk of HIV-1 infection ( p= 0.034, OR = 1.710, 95% CI:
1.039–2.814). After logistic regression analyses adjusted for
both age and sex, we observed the CCR5 59653-CT genotype
to be significantly associated with increased susceptibility to
HIV-1 infection among a Northern Han Chinese population.
The combined genotypes CT/TT also contribute to the higher
risk of HIV-1 infection, indicating that the T allele of CCR5
59653 has a negative effect on HIV-1 infection for its carriers.
No other associations between the allelic and genotypic fre-
quencies and susceptibility to HIV-1 infection reached statis-
tical significance ( p > 0.05), which is not consistent with
previous reports in other ethnic populations (Kostrikis et al.,
1999; Clegg et al., 2000; de Souza et al., 2006; Kaur et al., 2007).
Some scholars accepted the concordant conclusion that
HIV-1-infected individuals carrying the CCR5 59029-GG ge-
notype progress to AIDS more slowly than those carrying
FIG. 2. Interaction dendrogram. The different color con-
nections show the degree of interaction: synergy (black and
dark gray) or redundancy (light gray).
Table 5. Logistic Regression Model of Main Effect and Gene–Gene Interaction on Human
Immunodeficiency Virus-1 Infection Risk Based on Multifactor Dimensionality Reduction
Variable Genotype p-Value Adjusted OR (95% CI)a
Age 0.823 1.004 (0.970–1.039)
Gender 0.297 1.396 (0.745–2.616)
CCR5 58755-A/G AA 0.057 1.000
AG 10.673 (1.373–82.972)
GG 0.965 (0.070–13.302)
CCR5 59029-A/G AA 0.025b 1.000
AG 5.671 (1.394–23.073)
GG 2.888 (0.689–12.110)
CCR5 58755-A/G*CCR5 59029-A/G AA/AA 0.014b 1.000
AG/AG 0.025 (0.003–0.235)
AG/GG 0.026 (0.001–0.544)
GG/GG —
aAdjusted for age and gender in the logistic regression model.
bSignificant at the level of p< 0.05.
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CCR5 59029-AA (McDermott et al., 1998; Clegg et al., 2000;
Knudsen et al., 2001; Kaur et al., 2007). In Brazilian children,
the presence of theCCR5 59353-TT genotype indicated a trend
for increased risk of vertical transmission of HIV-1 infection
(de Souza et al., 2006). The CCR5 59356-T allele is associated
with an increased incidence of perinatal HIV-1 transmission
in the African-American and sub-Saharan African popula-
tions (Kostrikis et al., 1999; Singh et al., 2008). In the Korean
population, no significant differences of CCR5 59029-G/A,
59353-T/C, and 59402-A/G between HIV-1-infected patients
and controls were found ( Jang et al., 2008).
Although the CCR2-V64I polymorphism does not affect
susceptibility to HIV-1 infection, HIV-1-infected persons car-
rying the CCR2-V64I allele show a slower progression to
AIDS (Smith et al., 1997; Anzala et al., 1998; Kostrikis et al.,
1998; Wasik et al., 2005). However, some studies do not sup-
port this conclusion (Lee et al., 1998; Mummidi et al., 1998). In
this study, the frequency of the CCR2-64I allele is 23.6% for
cases and 18.1% for controls, respectively, and no significant
association is identified between CCR2-V64I and HIV-1 in-
fection ( p= 0.197). An in vivo study reported that protein en-
coded by the CCR2-V64I mutant can cross-regulate the
receptor-signaling process of the major HIV-1 coreceptors
CCR5 and CXCR4, and thus reduce the interaction between
HIV-1 and CCR5, as well as CXCR4, explaining the effect of
the CCR2-V64I polymorphism on progression to AIDS (Lee
et al., 1998). It has been suggested that there is an LD between
CCR2-V64I and other mutations in the CCR5 promoter region
(Smith et al., 1997; Kostrikis et al., 1998; Lee et al., 1998). In this
study,CCR2-V64I has complete LDwith theCCR5 58755A/G,
59029-A/G, 59353-T/C, and 59402-A/G polymorphisms in a
Northern Han Chinese population, suggesting that CCR2-
V64I and CCR5 promoter polymorphisms may jointly influ-
ence the process of HIV-1 infection.
The distribution of haplotypes in CCR5 promoter is highly
variable in different populations, and a number of CCR5
haplotypes have been shown to influence HIV-1 infection
(Arenzana-Seisdedos and Parmentier, 2006). In the Caucasian
populations, the haplotype ACCAC is associated with both
increased risk and an accelerated course of infection (Li et al.,
2005), but not among African-Americans (Mummidi et al.,
2000). We observed that a haplotype TATGC of the CCR5
promoter region is significantly different between HIV-1-in-
fected patients and healthy controls, showing that haplotype
TATGC is associated with higher susceptibility of HIV-1 in-
fection in a Northern Han Chinese population.
According to the LD results of the targeted loci through
pairwise analyses, different LD degree between cases and
controls was found, suggesting that there is an SNP-SNP in-
teraction influencing the risk of HIV-1 infection in a Northern
Han Chinese population. In the two-factor model of MDR
methods, the strongest interaction is between theCCR5 58755-
A/G andCCR5 59029-A/G polymorphisms, showing that the
CCR5 58755A/G and CCR5 59029-A/G polymorphisms
jointly contribute to the susceptibility of HIV-1 infection in a
Northern Han Chinese population. The logistic regression
analysis further validated that the interaction of the CCR5
58755-A/G and CCR5 59029-A/G polymorphisms decreases
the susceptibility of HIV-1 infection in the Han Chinese
population. In addition, the potential interaction effects of the
CCR5 promoter and CCR2-V64I polymorphism on the risk of
HIV-1 infection were also examined in the three-factor model,
including CCR5 58755-A/G, CCR5 59029-A/G, and CCR2-
V64I polymorphisms. To some extent, there are significant
interactions between theCCR5 promoter region and theCCR2
gene affecting HIV-1 infection in a Northern Han Chinese
population.
There are two limitations in this study. Our findings are
only from a Northern Han Chinese population, so it is un-
certain whether these results are relevant to other ethnic
groups. Secondly, MDR and logistic analyses cannot explain
the biological mechanism of this observed gene–gene inter-
action. Therefore, further research at a biochemical level is
required to confirm the results of the present study.
In conclusion, this study detects an associated relationship
of the CCR5 promoter and CCR2 polymorphisms with the
susceptibility of HIV-1 infection at allelic, genotypic, and
haplotypic levels. Individuals with the A allele of CCR5
58755-A/G, T allele of CCR5 59653-C/T, or TATGC haplo-
type are more susceptible to HIV-1 infection in Northern Han
Chinese. Furthermore, this study suggests that the epistatic
effects of the CCR5 58755-A/G and CCR5 59029-A/G poly-
morphisms significantly decrease susceptibility of HIV-1 in-
fection in Northern Han Chinese. These findings expand the
understanding of the genetic mechanism of the CCR5 pro-
moter andCCR2-V64I polymorphisms contributing to the risk
of HIV-1 infection in a Northern Chinese Han population.
Acknowledgments
All subjects enrolled in the present study were gratefully
acknowledged. The study was funded by the National 12th 5-
year Plan Project (2012BAI37B03), National Natural Science
Foundation of China (31070727, 81001281, 30901238, and
30800949), National Basic Research Program 973 of China
(2011CB503806), and Novel Star of Science Program, Beijing,
China (No: 2009A47).
Author Disclosure Statement
No competing financial interests exist.
References
Anzala AO, Ball TB, et al. (1998) CCR2-64I allele and genotype
association with delayed AIDS progression in African women.
University of Nairobi Collaboration for HIV Research. Lancet
351:1632–1633.
Arenzana-Seisdedos F, Parmentier M (2006) Genetics of resis-
tance to HIV infection: role of co-receptors and co-receptor
ligands. Semin Immunol 18:387–403.
Berger EA, Doms RW, et al. (1998) A new classification for HIV-
1. Nature 391:240.
Carrington M, Dean M, et al. (1999) Genetics of HIV-1 infection:
chemokine receptor CCR5 polymorphism and its conse-
quences. Hum Mol Genet 8:1939–1945.
Clegg AO, Ashton LJ, et al. (2000) CCR5 promoter polymor-
phisms, CCR5 59029A and CCR5 59353C, are under re-
presented in HIV-1-infected long-term non-progressors. The
Australian Long-Term Non-Progressor Study Group. AIDS
14:103–108.
Cordell HJ (2009) Detecting gene-gene interactions that underlie
human diseases. Nat Rev Genet 10:392–404.
de Souza PR, Arraes LC, et al. (2006) CCR5 promoter polymor-
phisms and HIV-1 perinatal transmission in Brazilian children.
J Reprod Immunol 69:77–84.
1374 LU ET AL.
Dean M, Carrington M, et al. (2002) Balanced polymorphism
selected by genetic versus infectious human disease. Annu
Rev Genomics Hum Genet 3:263–292.
Easterbrook PJ, Rostron T, et al. (1999) Chemokine receptor
polymorphisms and human immunodeficiency virus disease
progression. J Infect Dis 180:1096–1105.
Gonzalez E, Bamshad M, et al. (1999) Race-specific HIV-1 dis-
ease-modifying effects associated with CCR5 haplotypes. Proc
Natl Acad Sci U S A 96:12004–12009.
Hahn LW, Ritchie MD, et al. (2003) Multifactor dimensionality
reduction software for detecting gene-gene and gene-
environment interactions. Bioinformatics 19:376–382.
Hogan CM, Hammer SM (2001) Host determinants in HIV in-
fection and disease. Part 2: genetic factors and implications for
antiretroviral therapeutics. Ann Intern Med 134:978–996.
Huang Y, Paxton WA, et al. (1996) The role of a mutant CCR5
allele in HIV-1 transmission and disease progression. Nat Med
2:1240–1243.
Jang DH, Choi BS, et al. (2008) The effects of RANTES/CCR5
promoter polymorphisms on HIV disease progression in HIV-
infected Koreans. Int J Immunogenet 35:101–105.
Kaur G, Singh P, et al. (2007) Polymorphism in the CCR5 gene
promoter and HIV-1 infection in North Indians. Hum Im-
munol 68:454–461.
Knudsen TB, Kristiansen TB, et al. (2001) Adverse effect of the
CCR5 promoter - 2459A allele on HIV-1 disease progression. J
Med Virol 65:441–444.
Kostrikis LG, Huang Y, et al. (1998) A chemokine receptor CCR2
allele delays HIV-1 disease progression and is associated with
a CCR5 promoter mutation. Nat Med 4:350–353.
Kostrikis LG, Neumann AU, et al. (1999) A polymorphism in the
regulatory region of the CC-chemokine receptor 5 gene influ-
ences perinatal transmission of human immunodeficiency virus
type 1 to African-American infants. J Virol 73:10264–10271.
Lee B, Doranz BJ, et al. (1998) Influence of the CCR2-V64I
polymorphism on human immunodeficiency virus type 1
coreceptor activity and on chemokine receptor function of
CCR2b, CCR3, CCR5, and CXCR4. J Virol 72:7450–7458.
Li M, Song R, et al. (2005) Association of CCR5 human hap-
logroup E with rapid HIV type 1 disease progression. AIDS
Res Hum Retroviruses 21:111–115.
Liu R, Paxton WA, et al. (1996) Homozygous defect in HIV-1
coreceptor accounts for resistance of some multiply-exposed
individuals to HIV-1 infection. Cell 86:367–377.
Martinson JJ, Chapman NH, et al. (1997) Global distribution of
the CCR5 gene 32-basepair deletion. Nat Genet 16:100–103.
McDermott DH, Zimmerman PA, et al. (1998) CCR5 promoter
polymorphism and HIV-1 disease progression. Multicenter
AIDS Cohort Study (MACS). Lancet 352:866–870.
Moore JH (2003) The ubiquitous nature of epistasis in deter-
mining susceptibility to common human diseases. Hum Hered
56:73–82.
Mummidi S, Ahuja SS, et al. (1998) Genealogy of the CCR5 locus
and chemokine system gene variants associated with altered
rates of HIV-1 disease progression. Nat Med 4:786–793.
Mummidi S, Bamshad M, et al. (2000) Evolution of human and
non-human primate CC chemokine receptor 5 gene and
mRNA. Potential roles for haplotype and mRNA diversity,
differential haplotype-specific transcriptional activity, and al-
tered transcription factor binding to polymorphic nucleotides
in the pathogenesis of HIV-1 and simian immunodeficiency
virus. J Biol Chem 275:18946–18961.
O’Brien TR, Winkler C, et al. (1997) HIV-1 infection in a man
homozygous for CCR5 delta 32. Lancet 349:1219.
Pantaleo G, Fauci AS (1996) Immunopathogenesis of HIV in-
fection. Annu Rev Microbiol 50:825–854.
Ritchie MD, Hahn LW, et al. (2001) Multifactor-dimensionality
reduction reveals high-order interactions among estrogen-
metabolism genes in sporadic breast cancer. Am J Hum Genet
69:138–147.
Rizzardi GP, Morawetz RA, et al. (1998) CCR2 polymorphism
and HIV disease. Swiss HIV Cohort. Nat Med 4:252–253.
Samson M, Labbe O, et al. (1996a) Molecular cloning and func-
tional expression of a new human CC-chemokine receptor
gene. Biochemistry 35:3362–3367.
Samson M, Soularue P, et al. (1996b) The genes encoding the
human CC-chemokine receptors CC-CKR1 to CC-CKR5
(CMKBR1-CMKBR5) are clustered in the p21.3-p24 region of
chromosome 3. Genomics 36:522–526.
Simmons G, Wilkinson D, et al. (1996) Primary, syncytium-
inducing human immunodeficiency virus type 1 isolates are
dual-tropic and most can use either Lestr or CCR5 as cor-
eceptors for virus entry. J Virol 70:8355–8360.
Singh KK, Hughes MD, et al. (2008) Associations of chemokine
receptor polymorphisms with HIV-1 mother-to-child transmis-
sion in sub-Saharan Africa: possible modulation of genetic effects
by antiretrovirals. J Acquir Immune Defic Syndr 49:259–265.
Smith MW, Dean M, et al. (1997) Contrasting genetic influence of
CCR2 and CCR5 variants on HIV-1 infection and disease
progression. Hemophilia Growth and Development Study
(HGDS), Multicenter AIDS Cohort Study (MACS), Multi-
center Hemophilia Cohort Study (MHCS), San Francisco City
Cohort (SFCC), ALIVE Study. Science 277:959–965.
Su B, Chakraborty R, et al. (1998) An HIV-resistant allele is
exceptionally frequent in New Guinean highlanders. JAMA
280:1830.
Wang F, Jin L, et al. (2001) Genotypes and polymorphisms of
mutant CCR5-delta 32, CCR2-64I and SDF1-3¢ a HIV-1 resis-
tance alleles in indigenous Han Chinese. Chin Med J (Engl)
114:1162–1166.
Wasik TJ, Smolen J, et al. (2005) Effects of CCR5-delta32, CCR2-
64I and SDF-1-3¢A polymorphic alleles on human immuno-
deficiency virus 1 (HIV-1) infection in the Polish population.
Wiad Lek 58:500–507.
Xu L, Qiao Y, et al. (2009) CCR2-64I allele is associated with the
progression of AIDS in a Han Chinese population. Mol Biol
Rep 37:311–316.
Xu L, Qiao Y, et al. (2010) A haplotype in the CCR5 gene pro-
moter was associated with the susceptibility to HIV-1 infection
in a northern Chinese population. Mol Biol Rep 38:327–332.
Zhao J, Jin L et al. (2006) Test for interaction between two un-
linked loci. Am J Hum Genet 79:831–845.
Address correspondence to:
Wei Wang, M.D., Ph.D., FFPH
College of Life Science
University of Chinese Academy of Sciences
Beijing 100049
China
E-mail: wei.wang@ecu.edu.au
Manshu Song, Ph.D.
School of Public Health and Family Medicine
Capital Medical University
Beijing 100069
China
E-mail: songms@ccmu.edu.cn
CCR5 AND CCR2 POLYMORPHISMS AND HIV-1 INFECTION 1375
